12:00 AM
Nov 08, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Adefovir dipivoxil nucleotide reverse transcriptase inhibitor regulatory update

The FDA's Antiviral Drugs Advisory Committee voted 13-1 against recommending approval for adefovir to treat HIV infection/AIDS (see...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >